nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—NFKB1—abdominal aortic aneurysm	0.886	1	CbGaD
Pranlukast—RNASE3—blood plasma—abdominal aortic aneurysm	0.00923	0.359	CbGeAlD
Pranlukast—IL5—connective tissue—abdominal aortic aneurysm	0.00446	0.174	CbGeAlD
Pranlukast—Candesartan—AGTR1—abdominal aortic aneurysm	0.00412	1	CrCbGaD
Pranlukast—MUC2—connective tissue—abdominal aortic aneurysm	0.00343	0.133	CbGeAlD
Pranlukast—MUC2—spinal cord—abdominal aortic aneurysm	0.00228	0.0885	CbGeAlD
Pranlukast—NFKB1—connective tissue—abdominal aortic aneurysm	0.00196	0.0761	CbGeAlD
Pranlukast—NFKB1—amb2 Integrin signaling—LRP1—abdominal aortic aneurysm	0.00195	0.0234	CbGpPWpGaD
Pranlukast—NFKB1—kidney—abdominal aortic aneurysm	0.00167	0.0648	CbGeAlD
Pranlukast—TNF—amb2 Integrin signaling—LRP1—abdominal aortic aneurysm	0.00149	0.0178	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.00135	0.0161	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.00133	0.0159	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.00103	0.0123	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—LDLR—abdominal aortic aneurysm	0.00102	0.0122	CbGpPWpGaD
Pranlukast—NFKB1—Oxidative Stress—SOD2—abdominal aortic aneurysm	0.000985	0.0118	CbGpPWpGaD
Pranlukast—CYP2C9—blood plasma—abdominal aortic aneurysm	0.000962	0.0374	CbGeAlD
Pranlukast—IL5—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.000959	0.0115	CbGpPWpGaD
Pranlukast—NFKB1—Osteopontin Signaling—MMP9—abdominal aortic aneurysm	0.000948	0.0113	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—MMP14—abdominal aortic aneurysm	0.000943	0.0113	CbGpPWpGaD
Pranlukast—NFKB1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—abdominal aortic aneurysm	0.000915	0.0109	CbGpPWpGaD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—abdominal aortic aneurysm	0.000905	0.0108	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—CCL2—abdominal aortic aneurysm	0.000848	0.0101	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00084	0.0101	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.00083	0.00993	CbGpPWpGaD
Pranlukast—NFKB1—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.00083	0.00993	CbGpPWpGaD
Pranlukast—NFKB1—IL1 and megakaryotyces in obesity—CCL2—abdominal aortic aneurysm	0.000812	0.00971	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.000795	0.00952	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—AGTR1—abdominal aortic aneurysm	0.000778	0.00931	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—LDLR—abdominal aortic aneurysm	0.000777	0.0093	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—NCF1—abdominal aortic aneurysm	0.000776	0.00929	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.000739	0.00885	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—AAAS—abdominal aortic aneurysm	0.000736	0.00881	CbGpPWpGaD
Pranlukast—CYP3A4—blood plasma—abdominal aortic aneurysm	0.000733	0.0285	CbGeAlD
Pranlukast—TNF—Alzheimers Disease—LRP1—abdominal aortic aneurysm	0.000723	0.00865	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—SERPINE1—abdominal aortic aneurysm	0.000705	0.00843	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.000659	0.00789	CbGpPWpGaD
Pranlukast—ABCC2—kidney—abdominal aortic aneurysm	0.000654	0.0254	CbGeAlD
Pranlukast—NFKB1—Vitamin B12 Metabolism—SOD2—abdominal aortic aneurysm	0.000645	0.00771	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—NOS2—abdominal aortic aneurysm	0.000636	0.00761	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.000632	0.00757	CbGpPWpGaD
Pranlukast—NFKB1—Osteopontin-mediated events—MMP2—abdominal aortic aneurysm	0.000629	0.00753	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—MMP2—abdominal aortic aneurysm	0.000613	0.00734	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.000608	0.00727	CbGpPWpGaD
Pranlukast—TNF—Overview of nanoparticle effects—PTGS2—abdominal aortic aneurysm	0.000608	0.00727	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—MMP9—abdominal aortic aneurysm	0.000607	0.00726	CbGpPWpGaD
Pranlukast—TNF—Monoamine Transport—AGT—abdominal aortic aneurysm	0.000596	0.00714	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—AGTR1—abdominal aortic aneurysm	0.000593	0.0071	CbGpPWpGaD
Pranlukast—NFKB1—IL1 and megakaryotyces in obesity—MMP9—abdominal aortic aneurysm	0.00058	0.00694	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—CCL2—abdominal aortic aneurysm	0.000574	0.00687	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.000562	0.00673	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—LDLR—abdominal aortic aneurysm	0.000556	0.00665	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SELL—abdominal aortic aneurysm	0.000549	0.00657	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—NFKB1—abdominal aortic aneurysm	0.000529	0.00633	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—APOE—abdominal aortic aneurysm	0.000528	0.00632	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.000524	0.00627	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000521	0.00623	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000519	0.0062	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—abdominal aortic aneurysm	0.000512	0.00613	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.000502	0.00601	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000494	0.00591	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.000492	0.00589	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—SOD2—abdominal aortic aneurysm	0.000491	0.00587	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—NOS2—abdominal aortic aneurysm	0.000485	0.0058	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.000479	0.00573	CbGpPWpGaD
Pranlukast—NFKB1—Osteopontin-mediated events—MMP9—abdominal aortic aneurysm	0.000473	0.00566	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—MMP2—abdominal aortic aneurysm	0.000467	0.00559	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—MMP9—abdominal aortic aneurysm	0.000461	0.00552	CbGpPWpGaD
Pranlukast—TNF—Canonical NF-kappaB pathway—NFKB1—abdominal aortic aneurysm	0.000453	0.00541	CbGpPWpGaD
Pranlukast—TNF—EBV LMP1 signaling—NFKB1—abdominal aortic aneurysm	0.000453	0.00541	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—CCL2—abdominal aortic aneurysm	0.000444	0.00531	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—CCL2—abdominal aortic aneurysm	0.000437	0.00523	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—NOS2—abdominal aortic aneurysm	0.000432	0.00517	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—MMP2—abdominal aortic aneurysm	0.000429	0.00513	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.000428	0.00512	CbGpPWpGaD
Pranlukast—IL5—Signaling by Interleukins—NFKB1—abdominal aortic aneurysm	0.000424	0.00507	CbGpPWpGaD
Pranlukast—NFKB1—IL-1 signaling pathway—CCL2—abdominal aortic aneurysm	0.000418	0.005	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000417	0.00498	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.000416	0.00498	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.000415	0.00496	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.000411	0.00492	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—APOE—abdominal aortic aneurysm	0.000403	0.00482	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.000401	0.00479	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.0004	0.00478	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000397	0.00474	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—SERPINE1—abdominal aortic aneurysm	0.000396	0.00474	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—abdominal aortic aneurysm	0.000396	0.00473	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000395	0.00473	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.000393	0.0047	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—abdominal aortic aneurysm	0.00039	0.00467	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000382	0.00456	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—MMP9—abdominal aortic aneurysm	0.000371	0.00444	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00037	0.00443	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00037	0.00442	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000366	0.00438	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—AGT—abdominal aortic aneurysm	0.000362	0.00433	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.000361	0.00432	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—MMP2—abdominal aortic aneurysm	0.000352	0.00421	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—MMP9—abdominal aortic aneurysm	0.000351	0.0042	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—SOD2—abdominal aortic aneurysm	0.000351	0.0042	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—NFKB1—abdominal aortic aneurysm	0.000348	0.00416	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.000344	0.00411	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.000341	0.00408	CbGpPWpGaD
Pranlukast—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—abdominal aortic aneurysm	0.000339	0.00406	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—CCL2—abdominal aortic aneurysm	0.000338	0.00405	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.000337	0.00404	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.000337	0.00403	CbGpPWpGaD
Pranlukast—CYP3A4—kidney—abdominal aortic aneurysm	0.000332	0.0129	CbGeAlD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—abdominal aortic aneurysm	0.000327	0.00391	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000317	0.0038	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000317	0.00379	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.000316	0.00378	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000316	0.00378	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000312	0.00374	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.000312	0.00373	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.000309	0.0037	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—SERPINE1—abdominal aortic aneurysm	0.000302	0.00361	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000301	0.0036	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.0003	0.00358	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—AAAS—abdominal aortic aneurysm	0.000299	0.00358	CbGpPWpGaD
Pranlukast—IL5—Immune System—SELL—abdominal aortic aneurysm	0.000288	0.00344	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.000287	0.00343	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—APOE—abdominal aortic aneurysm	0.000284	0.00339	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000284	0.00339	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—MMP9—abdominal aortic aneurysm	0.000283	0.00338	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—abdominal aortic aneurysm	0.00028	0.00335	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00028	0.00334	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000277	0.00331	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—AGT—abdominal aortic aneurysm	0.000276	0.0033	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.000275	0.00329	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000268	0.00321	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—MMP9—abdominal aortic aneurysm	0.000265	0.00317	CbGpPWpGaD
Pranlukast—TNF—TNF receptor signaling pathway —NFKB1—abdominal aortic aneurysm	0.00026	0.00311	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.00026	0.00311	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—CDKN2A—abdominal aortic aneurysm	0.00026	0.00311	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.000258	0.00309	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.000257	0.00307	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—CCL2—abdominal aortic aneurysm	0.000257	0.00307	CbGpPWpGaD
Pranlukast—TNF—Ceramide signaling pathway—NFKB1—abdominal aortic aneurysm	0.000251	0.00301	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.000244	0.00292	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—CDKN2A—abdominal aortic aneurysm	0.000244	0.00291	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—abdominal aortic aneurysm	0.000243	0.00291	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.000241	0.00289	CbGpPWpGaD
Pranlukast—IL5—Immune System—AAAS—abdominal aortic aneurysm	0.00024	0.00288	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.000239	0.00286	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000234	0.0028	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—abdominal aortic aneurysm	0.000232	0.00278	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—NFKB1—abdominal aortic aneurysm	0.000229	0.00274	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—NFKB1—abdominal aortic aneurysm	0.000225	0.0027	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000224	0.00268	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000223	0.00267	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.000219	0.00262	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—abdominal aortic aneurysm	0.000217	0.0026	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000211	0.00252	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—CDKN2A—abdominal aortic aneurysm	0.000211	0.00252	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000204	0.00244	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000204	0.00244	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000198	0.00237	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CDKN2A—abdominal aortic aneurysm	0.000198	0.00237	CbGpPWpGaD
Pranlukast—IL5—Immune System—NCF1—abdominal aortic aneurysm	0.000196	0.00235	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.000195	0.00233	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—AGT—abdominal aortic aneurysm	0.000194	0.00232	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NOS2—abdominal aortic aneurysm	0.000193	0.00231	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.000193	0.00231	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.000192	0.00229	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00019	0.00227	CbGpPWpGaD
Pranlukast—TNF—Signaling events mediated by HDAC Class I—NFKB1—abdominal aortic aneurysm	0.000186	0.00222	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000184	0.0022	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000179	0.00214	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000178	0.00213	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—SOD2—abdominal aortic aneurysm	0.000173	0.00207	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.000173	0.00207	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000173	0.00206	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—abdominal aortic aneurysm	0.000172	0.00206	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00017	0.00203	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000168	0.002	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000163	0.00195	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—abdominal aortic aneurysm	0.000161	0.00192	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—NFKB1—abdominal aortic aneurysm	0.000161	0.00192	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000155	0.00185	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000154	0.00184	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—SERPINE1—abdominal aortic aneurysm	0.000149	0.00179	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000149	0.00179	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.000141	0.00169	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00014	0.00167	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN2A—abdominal aortic aneurysm	0.000138	0.00164	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000137	0.00164	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000136	0.00163	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000136	0.00162	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000134	0.0016	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000132	0.00157	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000129	0.00154	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000127	0.00152	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000126	0.00151	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000124	0.00148	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.000124	0.00148	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000121	0.00145	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00012	0.00144	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SELL—abdominal aortic aneurysm	0.000117	0.0014	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000115	0.00137	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000115	0.00137	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00011	0.00132	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—abdominal aortic aneurysm	0.000107	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2A—abdominal aortic aneurysm	0.000104	0.00124	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000102	0.00122	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.0001	0.0012	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	9.79e-05	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AAAS—abdominal aortic aneurysm	9.77e-05	0.00117	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LDLR—abdominal aortic aneurysm	9.74e-05	0.00117	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	9.6e-05	0.00115	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	9.59e-05	0.00115	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	9.22e-05	0.0011	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NCF1—abdominal aortic aneurysm	9.11e-05	0.00109	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP3—abdominal aortic aneurysm	9.09e-05	0.00109	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AGT—abdominal aortic aneurysm	8.72e-05	0.00104	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	8.32e-05	0.000996	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NCF1—abdominal aortic aneurysm	7.98e-05	0.000955	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	7.32e-05	0.000875	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LRP1—abdominal aortic aneurysm	7.28e-05	0.000871	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	7.18e-05	0.000859	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AGT—abdominal aortic aneurysm	7.17e-05	0.000858	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—abdominal aortic aneurysm	7.03e-05	0.000841	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP2—abdominal aortic aneurysm	6.87e-05	0.000822	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	6.81e-05	0.000814	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	6.52e-05	0.00078	CbGpPWpGaD
Pranlukast—IL5—Immune System—NFKB1—abdominal aortic aneurysm	6.47e-05	0.000774	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.91e-05	0.000707	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.52e-05	0.00066	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LDLR—abdominal aortic aneurysm	5.52e-05	0.00066	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP2—abdominal aortic aneurysm	5.23e-05	0.000626	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—abdominal aortic aneurysm	5.16e-05	0.000618	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NCF1—abdominal aortic aneurysm	5.16e-05	0.000617	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AGT—abdominal aortic aneurysm	5.15e-05	0.000616	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—abdominal aortic aneurysm	5.05e-05	0.000604	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	4.62e-05	0.000553	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.24e-05	0.000507	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.23e-05	0.000505	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.18e-05	0.0005	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	4.14e-05	0.000496	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.96e-05	0.000474	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—abdominal aortic aneurysm	3.93e-05	0.000471	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NFKB1—abdominal aortic aneurysm	3.89e-05	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP3—abdominal aortic aneurysm	3.69e-05	0.000442	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.03e-05	0.000363	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3e-05	0.000359	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGT—abdominal aortic aneurysm	2.92e-05	0.000349	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—abdominal aortic aneurysm	2.86e-05	0.000342	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	2.44e-05	0.000292	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.4e-05	0.000287	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	2.39e-05	0.000286	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	2.36e-05	0.000282	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.24e-05	0.000268	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	2.06e-05	0.000246	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.72e-05	0.000205	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.64e-05	0.000196	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	1.56e-05	0.000186	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	1.36e-05	0.000162	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	1.09e-05	0.00013	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	1.07e-05	0.000128	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	7.3e-06	8.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	7.18e-06	8.58e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	7.03e-06	8.41e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	4.82e-06	5.76e-05	CbGpPWpGaD
